50242-0103 POLIVY - CanMED: NDC

Product NDC:

50242-0103

Brand Name:

POLIVY

Generic Name:

polatuzumab vedotin

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: POLATUZUMAB VEDOTIN

Strength: 30.0

Unit: mg/1.88mL

Packages:

Code: 50242-0103-01

Description: 1 VIAL in 1 CARTON (50242-103-01) / 6 mL in 1 VIAL

Effective Date: Sept. 18, 2020

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Drug Antibody Conjugate

Minor Class:

CD79b

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox